Margaret Bigwood Pulsifer, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Down Syndrome | 12 | 2022 | 880 | 1.220 |
Why?
|
| Medulloblastoma | 8 | 2021 | 683 | 1.170 |
Why?
|
| Intelligence | 12 | 2020 | 920 | 0.980 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 3 | 2024 | 501 | 0.890 |
Why?
|
| Brain Neoplasms | 11 | 2024 | 8861 | 0.850 |
Why?
|
| Cerebellar Neoplasms | 5 | 2021 | 587 | 0.810 |
Why?
|
| Implantable Neurostimulators | 2 | 2021 | 77 | 0.800 |
Why?
|
| Mutism | 1 | 2019 | 24 | 0.700 |
Why?
|
| Cognition | 14 | 2024 | 6770 | 0.700 |
Why?
|
| Tuberous Sclerosis | 8 | 2013 | 1029 | 0.660 |
Why?
|
| Electric Stimulation Therapy | 2 | 2021 | 605 | 0.650 |
Why?
|
| Cognition Disorders | 9 | 2021 | 4043 | 0.510 |
Why?
|
| Sleep Apnea, Obstructive | 3 | 2022 | 1813 | 0.480 |
Why?
|
| Executive Function | 3 | 2024 | 1364 | 0.480 |
Why?
|
| Neuropsychological Tests | 15 | 2024 | 6994 | 0.450 |
Why?
|
| Psychological Tests | 2 | 2007 | 651 | 0.430 |
Why?
|
| Child Behavior Disorders | 3 | 2008 | 807 | 0.400 |
Why?
|
| Memory Disorders | 1 | 2018 | 1186 | 0.370 |
Why?
|
| Hypoglossal Nerve | 2 | 2021 | 95 | 0.370 |
Why?
|
| Child | 39 | 2024 | 77709 | 0.360 |
Why?
|
| Prenatal Exposure Delayed Effects | 6 | 2007 | 2408 | 0.310 |
Why?
|
| Child, Preschool | 32 | 2021 | 41005 | 0.300 |
Why?
|
| Telemedicine | 2 | 2021 | 2872 | 0.300 |
Why?
|
| Hippocampus | 3 | 2018 | 3675 | 0.290 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2015 | 895 | 0.290 |
Why?
|
| Adolescent | 31 | 2024 | 85779 | 0.270 |
Why?
|
| Analysis of Variance | 5 | 2018 | 6366 | 0.260 |
Why?
|
| Child Development | 4 | 2003 | 2223 | 0.260 |
Why?
|
| Cocaine | 3 | 2007 | 1007 | 0.240 |
Why?
|
| Neuropil | 1 | 2024 | 30 | 0.240 |
Why?
|
| Quality of Life | 6 | 2022 | 12802 | 0.240 |
Why?
|
| Neuropsychology | 2 | 2021 | 110 | 0.230 |
Why?
|
| Hemispherectomy | 1 | 2004 | 44 | 0.230 |
Why?
|
| Ependymoma | 2 | 2018 | 334 | 0.220 |
Why?
|
| Young Adult | 17 | 2024 | 56429 | 0.210 |
Why?
|
| Wechsler Scales | 2 | 2018 | 260 | 0.210 |
Why?
|
| Cochlear Implants | 2 | 2004 | 339 | 0.200 |
Why?
|
| Speech Perception | 2 | 2004 | 490 | 0.200 |
Why?
|
| Presenilins | 1 | 2021 | 54 | 0.200 |
Why?
|
| Ketone Bodies | 1 | 2001 | 82 | 0.200 |
Why?
|
| Motor Skills | 3 | 2020 | 522 | 0.180 |
Why?
|
| Memory, Short-Term | 2 | 2017 | 977 | 0.180 |
Why?
|
| Parents | 5 | 2018 | 3405 | 0.170 |
Why?
|
| Child Behavior | 3 | 2003 | 839 | 0.170 |
Why?
|
| Protons | 3 | 2021 | 1127 | 0.170 |
Why?
|
| Hearing Loss, Sensorineural | 3 | 2020 | 770 | 0.170 |
Why?
|
| Male | 48 | 2022 | 350115 | 0.170 |
Why?
|
| Female | 47 | 2024 | 380193 | 0.170 |
Why?
|
| Craniopharyngioma | 2 | 2021 | 281 | 0.170 |
Why?
|
| Intelligence Tests | 3 | 2011 | 505 | 0.160 |
Why?
|
| Language Development Disorders | 1 | 2020 | 196 | 0.160 |
Why?
|
| Postoperative Period | 2 | 2019 | 1842 | 0.160 |
Why?
|
| Organs at Risk | 2 | 2018 | 346 | 0.160 |
Why?
|
| Cranial Irradiation | 2 | 2018 | 401 | 0.150 |
Why?
|
| Treatment Outcome | 16 | 2022 | 63107 | 0.150 |
Why?
|
| Cerebellar Diseases | 1 | 2019 | 226 | 0.150 |
Why?
|
| Humans | 62 | 2024 | 744366 | 0.150 |
Why?
|
| Functional Laterality | 1 | 2004 | 2290 | 0.140 |
Why?
|
| Mental Disorders | 4 | 2017 | 6598 | 0.140 |
Why?
|
| Alzheimer Disease | 4 | 2022 | 8038 | 0.140 |
Why?
|
| Inositol | 1 | 2017 | 218 | 0.130 |
Why?
|
| Epilepsy | 4 | 2012 | 3310 | 0.130 |
Why?
|
| Schools | 1 | 2004 | 1433 | 0.130 |
Why?
|
| Stress, Psychological | 2 | 2008 | 4245 | 0.130 |
Why?
|
| Developmental Disabilities | 3 | 2001 | 1456 | 0.130 |
Why?
|
| Cerebellum | 2 | 2019 | 1488 | 0.130 |
Why?
|
| Glioma | 3 | 2018 | 3401 | 0.130 |
Why?
|
| Longevity | 1 | 2021 | 1071 | 0.110 |
Why?
|
| Military Personnel | 1 | 2002 | 1133 | 0.110 |
Why?
|
| Vaccines | 1 | 2022 | 823 | 0.110 |
Why?
|
| Severity of Illness Index | 5 | 2021 | 15535 | 0.110 |
Why?
|
| Radiometry | 1 | 2018 | 800 | 0.110 |
Why?
|
| Adult | 25 | 2024 | 214052 | 0.110 |
Why?
|
| Neuroectodermal Tumors, Primitive | 1 | 2013 | 140 | 0.100 |
Why?
|
| Pituitary Neoplasms | 1 | 2021 | 1345 | 0.100 |
Why?
|
| Supratentorial Neoplasms | 1 | 2013 | 160 | 0.100 |
Why?
|
| Infant | 13 | 2021 | 35134 | 0.100 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2014 | 281 | 0.100 |
Why?
|
| Age Factors | 8 | 2018 | 18373 | 0.100 |
Why?
|
| Adaptation, Physiological | 1 | 2018 | 1312 | 0.100 |
Why?
|
| Pilot Projects | 2 | 2021 | 8319 | 0.100 |
Why?
|
| Seizures | 2 | 2001 | 2859 | 0.100 |
Why?
|
| Analgesics, Opioid | 1 | 2007 | 3677 | 0.100 |
Why?
|
| Photons | 1 | 2014 | 588 | 0.090 |
Why?
|
| Prospective Studies | 9 | 2022 | 53290 | 0.090 |
Why?
|
| Social Adjustment | 1 | 2012 | 631 | 0.090 |
Why?
|
| Comprehension | 1 | 2015 | 610 | 0.090 |
Why?
|
| Longitudinal Studies | 5 | 2020 | 13991 | 0.090 |
Why?
|
| Adaptation, Psychological | 2 | 2011 | 2575 | 0.090 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2018 | 1624 | 0.080 |
Why?
|
| Dementia | 4 | 1999 | 2518 | 0.080 |
Why?
|
| Mothers | 2 | 2001 | 2165 | 0.080 |
Why?
|
| Follow-Up Studies | 7 | 2018 | 39052 | 0.080 |
Why?
|
| Memory | 1 | 2018 | 2174 | 0.080 |
Why?
|
| Autistic Disorder | 2 | 2012 | 1185 | 0.080 |
Why?
|
| Child Development Disorders, Pervasive | 2 | 2011 | 615 | 0.070 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2013 | 957 | 0.070 |
Why?
|
| Phenotype | 4 | 2015 | 16367 | 0.070 |
Why?
|
| Age of Onset | 4 | 2021 | 3270 | 0.070 |
Why?
|
| Retrospective Studies | 12 | 2021 | 77460 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 15078 | 0.060 |
Why?
|
| Radiotherapy | 1 | 2012 | 1533 | 0.060 |
Why?
|
| Encephalitis | 2 | 1999 | 425 | 0.060 |
Why?
|
| Cochlear Aqueduct | 1 | 2004 | 7 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2011 | 2850 | 0.060 |
Why?
|
| Maternal Age | 1 | 2007 | 802 | 0.060 |
Why?
|
| Pandemics | 2 | 2021 | 8385 | 0.060 |
Why?
|
| Parent-Child Relations | 1 | 2008 | 747 | 0.060 |
Why?
|
| Radiotherapy Dosage | 3 | 2016 | 2879 | 0.060 |
Why?
|
| Pediatrics | 1 | 2018 | 3475 | 0.060 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2013 | 2305 | 0.050 |
Why?
|
| Meningitis | 1 | 2004 | 216 | 0.050 |
Why?
|
| Community Health Nursing | 1 | 2001 | 24 | 0.050 |
Why?
|
| Psychomotor Performance | 3 | 2007 | 1901 | 0.050 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2017 | 6036 | 0.050 |
Why?
|
| Brain | 6 | 2019 | 26388 | 0.050 |
Why?
|
| Emotions | 2 | 2015 | 2659 | 0.050 |
Why?
|
| Cerebral Cortex | 2 | 2013 | 5709 | 0.050 |
Why?
|
| Colombia | 1 | 2021 | 258 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2017 | 35425 | 0.050 |
Why?
|
| Germinoma | 1 | 2021 | 134 | 0.050 |
Why?
|
| Attention | 3 | 2015 | 2397 | 0.050 |
Why?
|
| Cooperative Behavior | 1 | 2007 | 1504 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 17446 | 0.040 |
Why?
|
| Audiometry, Pure-Tone | 1 | 2020 | 204 | 0.040 |
Why?
|
| Narcotics | 1 | 2001 | 343 | 0.040 |
Why?
|
| Cochlear Implantation | 1 | 2003 | 310 | 0.040 |
Why?
|
| Pregnancy | 6 | 2007 | 29144 | 0.040 |
Why?
|
| Moyamoya Disease | 1 | 2021 | 238 | 0.040 |
Why?
|
| Nausea | 1 | 2021 | 674 | 0.040 |
Why?
|
| Vomiting | 1 | 2021 | 637 | 0.040 |
Why?
|
| Patient Participation | 1 | 2007 | 1457 | 0.040 |
Why?
|
| Epidemiologic Methods | 1 | 2002 | 1364 | 0.040 |
Why?
|
| Fragile X Syndrome | 1 | 1998 | 115 | 0.040 |
Why?
|
| Family | 1 | 2007 | 3147 | 0.040 |
Why?
|
| Maternal Exposure | 1 | 2003 | 961 | 0.040 |
Why?
|
| Rett Syndrome | 1 | 1998 | 165 | 0.040 |
Why?
|
| Behavioral Symptoms | 1 | 1998 | 175 | 0.040 |
Why?
|
| Patient-Centered Care | 1 | 2007 | 1438 | 0.040 |
Why?
|
| Survivors | 2 | 2018 | 2291 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2022 | 12025 | 0.030 |
Why?
|
| Auditory Perception | 1 | 2020 | 569 | 0.030 |
Why?
|
| Parenting | 1 | 2001 | 679 | 0.030 |
Why?
|
| Middle Aged | 12 | 2013 | 213390 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2021 | 1915 | 0.030 |
Why?
|
| Sex Factors | 2 | 2021 | 10400 | 0.030 |
Why?
|
| Cohort Studies | 4 | 2022 | 40559 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2020 | 2618 | 0.030 |
Why?
|
| Alcohol Drinking | 1 | 2007 | 3966 | 0.030 |
Why?
|
| Testicular Neoplasms | 1 | 2021 | 806 | 0.030 |
Why?
|
| Substance-Related Disorders | 3 | 2003 | 4257 | 0.030 |
Why?
|
| Disease-Free Survival | 2 | 2016 | 6896 | 0.030 |
Why?
|
| Social Behavior | 1 | 2001 | 1127 | 0.030 |
Why?
|
| Optic Chiasm | 1 | 2014 | 87 | 0.030 |
Why?
|
| Basal Ganglia | 1 | 1997 | 546 | 0.030 |
Why?
|
| Vision Disorders | 1 | 2021 | 1058 | 0.030 |
Why?
|
| Fatigue | 1 | 2021 | 1531 | 0.030 |
Why?
|
| Radiation Injuries | 1 | 2021 | 1180 | 0.030 |
Why?
|
| Urban Population | 1 | 2001 | 2022 | 0.030 |
Why?
|
| Headache | 1 | 2021 | 1226 | 0.030 |
Why?
|
| Language Tests | 1 | 1993 | 202 | 0.030 |
Why?
|
| Decision Making | 1 | 2007 | 3888 | 0.030 |
Why?
|
| Aged | 2 | 2021 | 163288 | 0.030 |
Why?
|
| Pituitary Gland | 1 | 2014 | 665 | 0.020 |
Why?
|
| Amygdala | 1 | 1999 | 1315 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2021 | 5077 | 0.020 |
Why?
|
| Endocrine System Diseases | 1 | 2013 | 248 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 1996 | 1438 | 0.020 |
Why?
|
| Radiotherapy, Conformal | 1 | 2014 | 548 | 0.020 |
Why?
|
| Cross-Sectional Studies | 3 | 2014 | 25039 | 0.020 |
Why?
|
| Disease Progression | 2 | 2020 | 13286 | 0.020 |
Why?
|
| Speech | 1 | 2015 | 541 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2022 | 4561 | 0.020 |
Why?
|
| Language | 1 | 1999 | 1471 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2016 | 2971 | 0.020 |
Why?
|
| Baltimore | 2 | 2001 | 231 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 19905 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2022 | 3587 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2017 | 3914 | 0.020 |
Why?
|
| Genotype | 2 | 2015 | 12952 | 0.020 |
Why?
|
| Asthma | 1 | 2007 | 6010 | 0.020 |
Why?
|
| Motor Activity | 1 | 1998 | 2715 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2016 | 3616 | 0.020 |
Why?
|
| Role Playing | 1 | 2007 | 24 | 0.020 |
Why?
|
| Paternalism | 1 | 2007 | 46 | 0.020 |
Why?
|
| Nursing Assessment | 1 | 2007 | 107 | 0.020 |
Why?
|
| Nurse-Patient Relations | 1 | 2007 | 101 | 0.020 |
Why?
|
| Body Height | 1 | 2013 | 1578 | 0.020 |
Why?
|
| Temporal Lobe | 1 | 2014 | 1670 | 0.020 |
Why?
|
| Audiovisual Aids | 1 | 2007 | 92 | 0.020 |
Why?
|
| Electroencephalography | 2 | 2011 | 6151 | 0.020 |
Why?
|
| Central Nervous System | 1 | 2013 | 1357 | 0.020 |
Why?
|
| Twins, Monozygotic | 1 | 2007 | 458 | 0.020 |
Why?
|
| Penetrance | 1 | 2007 | 381 | 0.020 |
Why?
|
| Pediatric Nursing | 1 | 2007 | 103 | 0.020 |
Why?
|
| Mental Competency | 1 | 2007 | 176 | 0.020 |
Why?
|
| Diseases in Twins | 1 | 2007 | 449 | 0.020 |
Why?
|
| Social Support | 1 | 2015 | 2118 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 6539 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2013 | 3480 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 1997 | 12961 | 0.010 |
Why?
|
| Speech Intelligibility | 1 | 2004 | 81 | 0.010 |
Why?
|
| Population Surveillance | 1 | 1994 | 2616 | 0.010 |
Why?
|
| Atrophy | 2 | 1999 | 1584 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2017 | 6442 | 0.010 |
Why?
|
| Self Efficacy | 1 | 2007 | 615 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2011 | 4185 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2016 | 10252 | 0.010 |
Why?
|
| Cause of Death | 1 | 2013 | 3582 | 0.010 |
Why?
|
| Models, Psychological | 1 | 2007 | 811 | 0.010 |
Why?
|
| Infant, Newborn | 4 | 2007 | 25628 | 0.010 |
Why?
|
| Observer Variation | 1 | 2007 | 2593 | 0.010 |
Why?
|
| Self Care | 1 | 2007 | 786 | 0.010 |
Why?
|
| Prognosis | 2 | 2016 | 29060 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2016 | 11031 | 0.010 |
Why?
|
| Education | 1 | 2003 | 543 | 0.010 |
Why?
|
| Pedigree | 1 | 2007 | 4642 | 0.010 |
Why?
|
| Personality Assessment | 1 | 2001 | 647 | 0.010 |
Why?
|
| Crack Cocaine | 1 | 1998 | 32 | 0.010 |
Why?
|
| Affective Symptoms | 1 | 2001 | 407 | 0.010 |
Why?
|
| Body Constitution | 1 | 1998 | 278 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 14723 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2007 | 2278 | 0.010 |
Why?
|
| Sturge-Weber Syndrome | 1 | 1997 | 91 | 0.010 |
Why?
|
| Locomotion | 1 | 1998 | 378 | 0.010 |
Why?
|
| Cocaine-Related Disorders | 1 | 1999 | 460 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2016 | 23336 | 0.010 |
Why?
|
| Marijuana Abuse | 1 | 1998 | 403 | 0.010 |
Why?
|
| Time Factors | 1 | 2016 | 40075 | 0.010 |
Why?
|
| Communication | 1 | 2007 | 3750 | 0.010 |
Why?
|
| Home Care Services | 1 | 1999 | 606 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 1998 | 2887 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2007 | 6542 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 1998 | 3508 | 0.010 |
Why?
|
| Movement | 1 | 1998 | 1471 | 0.010 |
Why?
|
| Walking | 1 | 1998 | 1180 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1993 | 1681 | 0.010 |
Why?
|
| Gestational Age | 1 | 1999 | 3493 | 0.010 |
Why?
|
| Cerebrovascular Disorders | 1 | 1997 | 1504 | 0.010 |
Why?
|
| Birth Weight | 1 | 1998 | 2069 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 1998 | 21748 | 0.010 |
Why?
|
| Reference Values | 1 | 1997 | 4982 | 0.010 |
Why?
|
| Cost of Illness | 1 | 1997 | 1860 | 0.000 |
Why?
|
| Odds Ratio | 1 | 1999 | 9849 | 0.000 |
Why?
|
| Comorbidity | 1 | 1999 | 10388 | 0.000 |
Why?
|
| Logistic Models | 1 | 1999 | 13409 | 0.000 |
Why?
|
| Risk Factors | 1 | 2011 | 72296 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2007 | 57776 | 0.000 |
Why?
|
| Mutation | 1 | 2007 | 29786 | 0.000 |
Why?
|
| Brain Mapping | 1 | 1997 | 6670 | 0.000 |
Why?
|
| Multivariate Analysis | 1 | 1993 | 12244 | 0.000 |
Why?
|
| Aging | 1 | 1997 | 8664 | 0.000 |
Why?
|